These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31198311)

  • 21. Clinicoepidemiological study of adverse cutaneous drug reactions among immunocompromised children at a tertiary care hospital.
    Jarang T; Katakam BK; Bollepaka KK; Gindham H
    Indian J Sex Transm Dis AIDS; 2023; 44(1):24-29. PubMed ID: 37457520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study.
    Sinha S; Gupta K; Tripathy S; Dhooria S; Ranjan S; Pandey RM
    BMC Infect Dis; 2017 Dec; 17(1):761. PubMed ID: 29228918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.
    Mfinanga SG; Kirenga BJ; Chanda DM; Mutayoba B; Mthiyane T; Yimer G; Ezechi O; Connolly C; Kapotwe V; Muwonge C; Massaga J; Sinkala E; Kohi W; Lyantumba L; Nyakoojo G; Luwaga H; Doulla B; Mzyece J; Kapata N; Vahedi M; Mwaba P; Egwaga S; Adatu F; Pym A; Joloba M; Rustomjee R; Zumla A; Onyebujoh P
    Lancet Infect Dis; 2014 Jul; 14(7):563-71. PubMed ID: 24810491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness of pictogram intervention in the identification and reporting of adverse drug reactions in naïve HIV patients in Ethiopia: a cross-sectional study.
    Gebreyohannes EA; Bhagavathula AS; Abegaz TM; Abebe TB; Belachew SA; Tegegn HG; Mansoor SM
    HIV AIDS (Auckl); 2019; 11():9-16. PubMed ID: 30679928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse Drug Reactions to Antiretroviral Therapy in HIV-Infected Patients at the Largest Public Hospital in Nicaragua.
    Lorío M; Colasanti J; Moreira S; Gutierrez G; Quant C
    J Int Assoc Provid AIDS Care; 2014; 13(5):466-70. PubMed ID: 24935691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RETRACTED by plagiarism: Highly active antiretroviral therapy induced adverse drug reactions in Indian human immunodeficiency virus positive patients.
    Rajesh R; Vidyasagar S; Nandakumar K
    Pharm Pract (Granada); 2011 Jan; 9(1):48-55. PubMed ID: 25132890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in India.
    Shet A; Antony J; Arumugam K; Kumar Dodderi S; Rodrigues R; DeCosta A
    PLoS One; 2014; 9(3):e91028. PubMed ID: 24614165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients' economic outcomes in Eswatini.
    Steinert JI; Khan S; Mlambo K; Walsh FJ; Mafara E; Lejeune C; Wong C; Hettema A; Ogbuoji O; Vollmer S; De Neve JW; Mazibuko S; Okello V; Bärnighausen T; Geldsetzer P
    Elife; 2020 Aug; 9():. PubMed ID: 32831169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan.
    Hongo H; Nagao T; Nakamura K; Kitaichi T; Maeno Y; Tokunaga T; Fukuda A; Koga I
    Adv Ther; 2021 Aug; 38(8):4480-4504. PubMed ID: 34275116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse drug reactions to antiretroviral therapy: Results from spontaneous reporting system in Nigeria.
    Agu KA; Oparah AC
    Perspect Clin Res; 2013 Apr; 4(2):117-24. PubMed ID: 23833736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of a single-tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV-1-infected subjects on nonnucleoside reverse transcriptase inhibitor-containing first-line antiretroviral therapy in Pune, India.
    Dravid A; Betha TP; Sharma AK; Gawali R; Mahajan U; Kulkarni M; Saraf C; Kore S; Dravid M; Rathod N
    HIV Med; 2020 Oct; 21(9):578-587. PubMed ID: 33021066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-Term Adverse Drug Reactions to Antiretroviral Therapy in Children with HIV: A Cohort Study.
    Ray S; Seth A; Singh S; Sharma G; Gaur N; Shah Y; Kumar P; Chandra J
    Indian J Pediatr; 2023 Jan; 90(1):9-15. PubMed ID: 35113365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of antiretroviral therapy initiation time and baseline CD4
    Yang Y; Li Y; Zhang X; Zhang W; Ma Y; Jia X; Gondwe T; Wang Y; Shi X
    Glob Health Action; 2021 Jan; 14(1):1963527. PubMed ID: 34592916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between Medication Adherence Outcomes and Adverse Drug Reactions to Highly Active Antiretroviral Therapy in Indian Human Immunodeficiency Virus-Positive Patients.
    Rajesh R; Sudha V; Varma D; Sonika S
    J Young Pharm; 2012 Oct; 4(4):250-60. PubMed ID: 23492531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study to evaluate efficacy of second-line antiretroviral therapy given to human immunodeficiency virus patients at Antiretroviral Therapy Plus Centre in India.
    Modi JP; Kubavat A; Mundhava S; Lalwani U
    Indian J Sex Transm Dis AIDS; 2019; 40(1):51-56. PubMed ID: 31143861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy.
    Rajesh R; Vidyasagar S; Varma DM; Mohiuddin S; Noorunnisa
    Int J Risk Saf Med; 2011; 23(3):171-80. PubMed ID: 22020397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confirmation of factors that influence antiretroviral regimen change and the subsequent patient outcomes at a Regional Hospital in rural KwaZulu-Natal.
    Soorju V; Naidoo P
    Afr J Prim Health Care Fam Med; 2016 Oct; 8(1):e1-e6. PubMed ID: 28155312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.